The Goldman Sachs Group, Inc. 13D and 13G filings for Indivior Pharmaceuticals Inc:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2026-02-12 10:30 am Sale | 2025-12-31 | 13G | INDIVIOR PLC USD0.5 INDV | GOLDMAN SACHS GROUP INC GS | 3,592,431 2.900% | -2,939,438 (-45.00%) | Filing |
| 2025-11-12 3:50 pm Sale | 2025-09-30 | 13G | INDIVIOR PLC USD0.5 INDV | GOLDMAN SACHS GROUP INC GS | 6,531,869 5.200% | -3,257,300 (-33.27%) | Filing |
| 2025-08-13 5:48 pm Purchase | 2025-06-30 | 13G | INDIVIOR PLC USD0.5 INDV | GOLDMAN SACHS GROUP INC GS | 9,789,169 7.800% | 1,696,459 (+20.96%) | Filing |